z-logo
Premium
BRENTUXIMAB VEDOTIN PRIOR TO ALLOGENEIC STEM CELL TRANSPLANTATION IN HODGKIN'S LYMPHOMAS: A RETROSPECTIVE EXPERIENCE BY THE RETE EMATOLOGICA PUGLIESE (REP)
Author(s) -
Gaudio F.,
Mazza P.,
Mele A.,
Palazzo G.,
Carella A.,
Pastore D.,
Cascavilla N.,
Pavone V.,
Specchia G.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.172_2631
Subject(s) - medicine , incidence (geometry) , cumulative incidence , retrospective cohort study , brentuximab vedotin , graft versus host disease , transplantation , oncology , surgery , lymphoma , hodgkin lymphoma , physics , optics

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom